Physician profile
Monica Eckman
NPI 1619136967
$1,424.24
in general payments reported to CMS, 2019-2025
17 companies · $693 in 2025
The $693 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.35 · 2022: $14.76 · 2023: $297 · 2024: $404 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.14 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $176.22 | 2024-2025 | |
| Harmony Biosciences LLC | $159.22 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $146.40 | 2024-2025 | |
| Glaxosmithkline, LLC. | $145.34 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $111.46 | 2023-2025 | Dupixent |
| Abbvie INC. | $108.19 | 2023-2025 | |
| Philips North America LLC | $100.54 | 2023-2024 | (Ak6) Vest Therapy |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $90.38 | 2024-2025 | Tezspire, Fasenra, Airsupra |
| Verona Pharma, INC. | $57.35 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $52.46 | 2024-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $49.67 | 2024 | Lumryz |
| Genentech USA, INC. | $38.41 | 2023 | Xolair |
| Grifols USA, LLC | $35.52 | 2023-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $24.12 | 2023 | Hillrom - Vest System Model 105 Home Care |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $14.62 | 2025 | Yupelri |
| Insmed, INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Eckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.